BeOne Medicines makes prescription medicines, including BRUKINSA and TEVIMBRA, and sells them in several countries. It last closed at $413.26 on Nov 17, up 0.48% on the day. ONC last reported earnings on Wed, Aug 5, 2026. The average 12-month price target from 7 analysts is $454.00 (+9.9% from the last close), with a high of $476.00 and a low of $435.00. Analyst consensus is Strong Buy, based on the latest ratings from 7 firms (7 buy, 0 hold, 0 sell). In the past 30 days there were 7 dark pool prints totaling $5.9M, the largest $1.4M.
Each firm's latest rating on ONC in the past 90 days
Average 12-month target
$454.00
▲ 9.9% upside
Based on 7 analysts who set a price target on ONC in the past 90 days. The average target is $454.00, with a high of $476.00 and a low of $435.00, compared with the last close of $413.26.
Low $435.00Avg $454.00High $476.00
Blue marker: last close $413.26
Highest target$476.00
Average target$454.00
Lowest target$435.00
Latest rating changes
Morgan StanleyMaintained
Nov 13Buy$476
RBC CapitalTarget raised
Nov 6Buy$459 → $465
Truist SecuritiesTarget raised
Nov 6Buy$420 → $448
BarclaysTarget raised
Nov 6Buy$415 → $446
CitizensTarget raised
Nov 6Buy$405 → $463
Date
Firm
Action
Rating
Price target
Nov 13
Morgan Stanley
Maintained
Buy
$476
Nov 6
RBC Capital
Target raised
Buy
$459 → $465
Nov 6
Truist Securities
Target raised
Buy
$420 → $448
Nov 6
Barclays
Target raised
Buy
$415 → $446
Nov 6
Citizens
Target raised
Buy
$405 → $463
Loading…
Technical Analysis
ONC · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought
The stock is 6% above its 20 day and 10% above its 50 day average. It is 21% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 64), near overbought. The nearest support is the Pivot at $411.43, and the nearest resistance the Pivot R1 at $415.76.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 2.8%/day
Key levels
$424.7052 week high+2.8%
$424.70Swing high (Nov 10)+2.8%
$415.76Pivot R1+0.6%
$413.26Last close
$411.43Pivot−0.4%
$408.94Pivot S1−1.0%
$390.2420 day average−5.6%
$371.4650 day average−10.1%
$365.14Swing low (Aug 24)−11.6%
$353.24100 day average−14.5%
$328.49200 day average−20.5%
$253.9552 week low−38.5%
Indicators
RSI (14)
64.44
Strong, overbought above 70
Neutral
MACD
13.89
Above its signal line
Bullish
Stochastic
85.7
Near the top of its range
Overbought
ADX (14)
20.7
Weak trend
Williams %R
-14.8
Oversold below −80, overbought above −20
Overbought
CCI (20)
70.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+16.5%
Change over 10 sessions
Bullish
ATR (14)
$11.57
Typical daily range, 2.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, nearing overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNear overbought
VolatilityNormal, 5.9%/day
Key levels
$424.7052 week high+2.8%
$424.70Swing high (Nov 10)+2.8%
$415.76Pivot R1+0.6%
$413.26Last close
$411.43Pivot−0.4%
$408.94Pivot S1−1.0%
$390.2420 day average−5.6%
$371.4650 day average−10.1%
$365.14Swing low (Aug 24)−11.6%
$353.24100 day average−14.5%
$328.49200 day average−20.5%
$253.9552 week low−38.5%
Indicators
RSI (14)
69.27
Strong, overbought above 70
Neutral
MACD
23.64
Above its signal line
Bullish
Stochastic
91.3
Near the top of its range
Overbought
ADX (14)
27.6
Trending up
Williams %R
-13.0
Oversold below −80, overbought above −20
Overbought
CCI (20)
168.8
Oversold below −100, overbought above 100
Overbought
Rate of change
+19.3%
Change over 10 sessions
Bullish
ATR (14)
$24.52
Typical daily range, 5.9% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for ONC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ONC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ONC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ONC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ONC is in one of them and how their past ONC trades turned out.
BeOne Medicines makes prescription medicines, including BRUKINSA and TEVIMBRA, and sells them in markets including the U.S., China and Europe. It is headquartered in Basel, Switzerland. Its customers include patients, hospitals and government and private health insurance payors, which set the coverage and reimbursement terms that affect how its medicines are sold.